O
Oviva
Reimbursed digital care for obesity, type 2 diabetes and chronic conditions
About Oviva
Oviva is a European digital health company that provides reimbursed care for people with obesity and weight-related chronic conditions, including prediabetes, type 2 diabetes and hypertension. Its programmes combine a certified medical-device app with remote multidisciplinary clinical teams of doctors, dietitians, nurses, psychologists and health coaches.
Patients use the Oviva app to track meals, activity, weight and other health measures, message their care team and follow structured behaviour-change programmes, supported by AI tools for personalised feedback. In the UK, Oviva is an NHS partner delivering national and local programmes, including consultant-led specialist weight management with prescribing of weight-loss medication where appropriate. In Germany, its obesity therapy is a permanently listed digital health application (DiGA) that doctors prescribe and statutory health insurers pay for. In Switzerland, it is part of the reimbursed healthcare system.
Because care is paid for by national health systems and statutory insurers, most patients pay nothing. The company was founded in 2014 by Kai Eberhardt (CEO) and Manuel Baumann (CTO).
Source: Dealroom company dataNews
Open roles
Oviva in the Zurich ecosystem
The Oviva office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed6 investors entered at this stage
Tim Ringel
Eight Roads Ventures
AlbionVC
F-Prime
Partech
Tim Jackson
Series A3 investors entered at this stage
- WVWalking Ventures
MTIP
Earlybird Venture Capital
Source: Dealroom Talent Intelligence.
See Oviva on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.










